Express delivery and free returns within 21 days

Tuesday, June 28, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

spot_img

Osteoarthritis

Spaulding Rehabilitation Hospital at Harvard Medical School and Highland Instruments, Inc., Jointly Announce Release of ALGEA 2 Clinical Trial Results

The double-blinded randomized controlled trial studied 64 patients that underwent a course of Highland's ESStimâ„¢ therapy, given 20 minutes/day over 10 days and were assessed up to 8 weeks post therapy.

By using this website you agree to accept Medical Device News Magazine Privacy Policy